Annual Congress Copenhagen 2005

Saturday, 17.09.2005
Sunday, 18.09.2005
Monday, 17.09.2005
Tuesday, 20.09.2005
Wednesday, 21.09.2005

Citations should be made in the following way: Authors. Title. Eur Respir J 2005; 26: Suppl. 49, abstract number.

Material from 2005:

4063 Abstracts
739 Slide presentations
213 Webcasts
93 Handouts

Material from 2005: Show

Recent advances in graft dysfunction after lung transplantation

Oral Presentation
Chairs: A. Boehler (Zurich, Switzerland), G. Snell (Melbourne, Australia)

Download all media

Introduction: new therapeutic approaches to bronchiolitis obliterans G. Snell (Melbourne, Australia)
Azithromycin (AZI) inhibits the IL-17 induced IL-8 production in human airway smooth muscle cells (HASMC): a possible explanation for the beneficial effect in BOS? B. M. Vanaudenaerde, W. A. Wuyts, L. J. Dupont, N. Geudens, M. G. Demedts, D. E. Van Raemdonck, G. M. Verleden (Leuven, Belgium)
Hepatocyte growth factor (HGF) in lung allografts I. A. Forrest, C. Ward, D. M. Murphy, G. E. Johnson, A. J. Fisher, J. L. Lordan, P. A. Corris (Newcastle-upon-Tyne, United Kingdom)
Possible role of CCL19, CCL20 and CCL22 in post transplant bronchiolitis obliterans F. Meloni, M. Morosini, N. Solari, A. Marone Bianco, I. Passadore, S. Miserere, C. Pellegrini, P. Vitulo, E. Pozzi, A. M. Fietta (Pavia, Italy)
Extended measurement of exhaled nitric oxide in patients after lung transplantation M. Hofer, L. Mueller, C. Mahler, E. W. Russi, A. Boehler (Zurich, Switzerland)
Gabexate mesilate attenuates ischemia-reperfusion injury of lung grafts via the inhibition of neutrophil activation M. Suga, T. Tsunoda, S. Yamazaki, T. Nakatani (Suita, Japan)
The use of surfactant in severe reperfusion injury after lung transplantation A. Amital, D. Shitrit, D. Bendayan, Y. Raviv, M. R. Kramer (Petach Tikva, Israel)
Increased recipient VEGF serum level is a risk factor for severe reperfusion edema after lung transplantation K. Krenn, S. Taghavi, W. Klepetko, S. Aharinejad (Vienna, Austria)